Latest filing published 12 Feb 2020 for Timber Pharmaceuticals, Inc., €21k.
Filing timeline
BuySaleInsider track record
Timber Pharmaceuticals LLC: trading record in brief
All filings by Timber Pharmaceuticals LLC on record concern Timber Pharmaceuticals, Inc. In total, 2 filings cover trades dated 10 February 2020.
Sales make up the whole of the open-market record (1 sale, €502). Other entries cover 1 share grant.
On 12 February 2020 came the latest disclosure, a share grant for €21k in Timber Pharmaceuticals, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Timber Pharmaceuticals LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,255,336 shares@ US$0.0197.6% of flowCommon Stock, par value $0.01 per shareSEC:0000905718-20-000121:0
- 55,008 shares@ US$0.012.4% of flowCommon Stock, par value $0.01 per shareSEC:0000905718-20-000121:1
2 of 2 declarations